BIORCHESTRA

BIORCHESTRA, with offices in Daejeon, South Korea, and Cambridge, Massachusetts, is an innovative biotechnology company developing RNA-based therapeutics. Our goal is to shift the treatment paradigm from symptomatic care to transformative approaches for neurodegenerative diseases and other conditions. From novel target discovery to streamlined drug development, we are committed to becoming pioneers in RNA therapy.